Introduction: Juvenile nasal angiofibromas (JNA) are benign tumours occurring in adolescent males. The aetiology of these masses has not been defined clearly. These stand apart of the sinonasal masses due to the high vascularity and non-encapsulated growth that might extend to the nasal cavity,nasopharynx, pterygopalatine fossa, infratemporal fossa, orbit, sphenoid sinus, and middle cranial fossa. 1 Objectives: 1) To evaluate the percentage of JNA amongst all the nasal masses. 2) To categorisethe clinical features and socio-demographic profiles of JNA and other nasal masses. Design of Study: Retrospective study. Materials and Methods: The data for this study were collected from the admission register of ENT Department, RIMS, Ranchi during the period of July,2013 to December,2015. The total sample size for the study was 220. Templates were generated in MS Excel sheets and analysis was done using SSPS software (version 20). Results: Following the data analysis we came to the conclusion that 4.1% of all the nasal mass operated in Department of ENT, RIMS were JNA. All the patients with JNA were males, below age of 20 years, mostly tribals (77.8%) residing in rural areas (66.7%) of Jharkhand. These were very much similar to the results we obtained upon analysis of the data for rest of the nasal masses. Most common presenting complaints due to JNA were recurrent epistaxis (88.9%) and nasal obstruction (88.9%) followed by nasal discharge (66.7%), while for the other nasal masses the most common presenting complaints were nasal obstruction and nasal discharge. Conclusion: Most of the male teenagers presenting with recurrent epistaxis with nasal obstruction turn out to be having a JNA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.